Samsara Set To Disrupt $19B Telematics Industry: Analyst Predicts AI Dash Cam Expansion
Samsara reported is a leader in AI dash cam and is now disrupting the vehicle telematics industry. Analysts recommend buying with $37 target.
Demystifying HealthEquity: Insights From 11 Analyst Reviews
HealthEquity (NASDAQ:HQY) has been analyzed by 11 analysts in the last three months, revealing a diverse range of…
The Analyst Verdict: Williams Companies In The Eyes Of 11 Experts
Analysts’ ratings for Williams Companies (NYSE:WMB) over the last quarter vary from bullish to bearish, as provided by…
Gold Rises 1%; Accenture Shares Surge After Q3 Results
U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining over 50 points on Thursday.…
The Analyst Verdict: WESCO Intl In The Eyes Of 7 Experts
7 analysts have expressed a variety of opinions on WESCO Intl (NYSE:WCC) over the past quarter, offering a…
Why Is Gilead Sciences Stock Trading Higher On Thursday?
Gilead Sciences announced its Phase 3 PURPOSE 1 trial results showing 100% efficacy of twice-yearly injectable lenacapavir in preventing HIV-1 in cisgender women. The trial met key efficacy endpoints, demonstrating superiority over daily Truvada and background HIV incidence.
The Analyst Landscape: 6 Takes On Silence Therapeutics
Analysts’ ratings for Silence Therapeutics (NASDAQ:SLN) over the last quarter vary from bullish to bearish, as provided by…
The Latest Analyst Ratings For Genuine Parts
Across the recent three months, 8 analysts have shared their insights on Genuine Parts (NYSE:GPC), expressing a variety…
Deep Dive Into Femasys Stock: Analyst Perspectives (4 Ratings)
In the preceding three months, 4 analysts have released ratings for Femasys (NASDAQ:FEMY), presenting a wide array of…
BP Doubles Down On Biofuels: Buys Out Bunge Bioenergia for $1.4B
BP to acquire Bunge's 50% stake in joint venture for $1.4 billion, consolidating financial results and supporting growth in bioenergy.